Shares of Alvotech (NASDAQ:ALVOW – Get Free Report) fell 19.9% during trading on Wednesday . The company traded as low as $0.2003 and last traded at $0.2003. Approximately 1,650 shares were traded during mid-day trading, a decline of 66% from the average daily volume of 4,838 shares. The stock had previously closed at $0.25.
Alvotech Price Performance
The stock’s 50 day simple moving average is $0.25 and its two-hundred day simple moving average is $0.39.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Articles
- Five stocks we like better than Alvotech
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
